欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2008, Vol. 13 ›› Issue (12): 1325-1329.

• 基础研究 • 上一篇    下一篇

糖尿病性肥胖大鼠模型的建立及西布曲明对其治疗作用的研究

崔明霞1,2, 王磊1, 张宝来1, 路莉1, 王莉1, 郑荣梁2, 吴勇杰1   

  1. 1兰州大学基础医学院药理学研究所, 甘肃省新药临床前研究重点实验室, 兰州 730000, 甘肃;
    2兰州大学生命科学学院, 兰州 730000, 甘肃
  • 收稿日期:2008-11-11 修回日期:2008-12-22 发布日期:2020-10-30
  • 通讯作者: 吴勇杰,男,教授,硕士生导师,研究方向:生物技术药品临床前研究。E-mail:wuyj@lzu.edu.cn
  • 作者简介:崔明霞,女,博士生,讲师,研究方向:内分泌药理及生物技术药品临床前研究。E-mail:cmxlz@yahoo.com.cn
  • 基金资助:
    国家自然科学基金资助项目(30600770);甘肃省自然科学基金资助项目(3ZS051-A25-091)

Establishment of diabetic obese rat model and the therapeutic effects of sibutramine on it

CUI Ming-xia1,2, WANG Lei1, ZHANG Bao-lai1, LU Li1, WANG Li1, ZHENG Rong-liang2, WUYong-jie1   

  1. 1Institute of Pharmacology, School of BasicMedical Science, LanzhouUniversity, Gansu Key Laboratory of Preclinical Study for New Drug, Lanzhou 730000, Gansu, China;
    2School of Life Sciences, Lanzhou University, Lanzhou 730000, Gansu, China
  • Received:2008-11-11 Revised:2008-12-22 Published:2020-10-30

摘要: 目的 研究链脲佐菌素(STZ) 联合高营养饲料诱导的大鼠糖尿病性肥胖模型的特点, 以及盐酸西布曲明对此种模型的治疗作用。方法 先用小剂量STZ(25 mg/kg) 尾静脉注射诱导大鼠产生糖尿病, 再用高营养饲料喂养4 个月建立糖尿病性肥胖模型。盐酸西布曲明4 mg/kg 灌胃治疗17 d, 给药期间定时测定体重及摄食量, 15 d 时测定糖耐量, 实验终点时测定体重、内脏脂肪及右比目鱼肌重量;取血分离血清测定血脂、血糖和血清胰岛素水平, 并计算胰岛素抵抗指数。结果 模型组大鼠体重、内脏脂肪重量及系数均显著升高, 而右比目鱼肌系数显著降低;空腹血糖、血胰岛素水平显著升高, 并出现糖耐量异常及胰岛素抵抗;TG 水平显著升高, 而高密度脂蛋白胆固醇(HDLC)水平显著降低。盐酸西布曲明可减轻糖尿病肥胖大鼠的体重、内脏脂肪含量和系数, 改善高胰岛素血症和胰岛素抵抗, 降低血TG 水平, 同时升高HDL-C 水平。对右比目鱼肌系数, 血糖、总胆固醇和低密度脂蛋白胆固醇(LDL-C) 水平, 以及糖耐量无明显影响。结论 STZ 联合高营养饲料可成功诱导糖尿病性肥胖的大鼠模型, 盐酸西布曲明对大鼠糖尿病肥胖具有一定的治疗作用。

关键词: 肥胖, 糖尿病, 西布曲明, 大鼠

Abstract: AIM: To study the characteristics of diabetic obese rats induced by streptozotocin (STZ) combined with hyperalimentation animal feeds and the therapeutic effect of sibutramine on diabetes obese rats.METHODS: Rats were intravenously injected with low dose (25 mg/kg) of STZ and fed with hyperalimentation animal feeds for 4 months to establish diabetic obese rat model.The diabetic obese rats were treated with sibutramine 4 mg/kg for 17 days and the body weight and food intake daily were measured.The glucose tolerance was measured at the 15th day.At the end of the treatment, the body weight, abdominal viscera fat and right soleus muscle, the levels of blood lipid, blood sugar, insulinum demeshed in serum were measured and the insulin resistance index (FIRI) were calculated.RESULTS: The body weight, abdominal viscera fat weight and the coefficient in model rats increased significantly, but thelinea obliqua tibiae coefficient decreased significantly.The blood-fasting glocose, insulin level increased significantly, and the carbohydrate tolerance abnormality and insulin resistance occurred.The serum triglyceride (TG) level increased and the high-density lipoprotein cholesterol (HDL-C) decreased significantly.Sibutramine reduced the body weight, visceral fat mass and coefficient, ameliorated hyperinsulinemia and insulin resistant, and decreased the serum TG level and increased HDL-C level as well. But it had not obviously affected the soleus muscle coefficient, blood glucose, cholesterol and LDL-C level, and carbohydrate tolerance.CONCLUSION: The diabetic obese rat model could be induced by STZ and hyperalimentation animal feeds and sibutramine has therapeutic effect on obese diabetes rats.

Key words: obesity, diabetes, sibutramine, rat

中图分类号: